ALK-Abelló First Quarter 2025 Earnings: EPS: kr.1.60 (vs kr.1.10 in 1Q 2024)

Simply Wall St

May 09, 2025

ALK-Abelló (CPH:ALK B) First Quarter 2025 Results

Key Financial Results

Revenue: kr.1.52b (up 13% from 1Q 2024).
Net income: kr.354.0m (up 53% from 1Q 2024).
Profit margin: 23% (up from 17% in 1Q 2024). The increase in margin was driven by higher revenue.
EPS: kr.1.60 (up from kr.1.10 in 1Q 2024).

We check all companies for important risks. See what we found for ALK-Abelló in our free report.

earnings-and-revenue-growth — CPSE:ALK B Earnings and Revenue Growth May 9th 2025

All figures shown in the chart above are for the trailing 12 month (TTM) period

ALK-Abelló Earnings Insights

Looking ahead, revenue is forecast to grow 12% p.a. on average during the next 3 years, compared to a 5.8% growth forecast for the Pharmaceuticals industry in Europe.

Performance of the market in Denmark.

The company's shares are up 5.0% from a week ago.

Balance Sheet Analysis

Just as investors must consider earnings, it is also important to take into account the strength of a company's balance sheet. See our latest analysis on ALK-Abelló's balance sheet health.

If you're looking to trade ALK-Abelló, open an account with the lowest-cost platform trusted by professionals, Interactive Brokers.

With clients in over 200 countries and territories, and access to 160 markets, IBKR lets you trade stocks, options, futures, forex, bonds and funds from a single integrated account.

Enjoy no hidden fees, no account minimums, and FX conversion rates as low as 0.03%, far better than what most brokers offer.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.